King KL - Search Results

1

Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma.

Su CH, Tsay SH, Wu CC, Shyr YM, King KL, Lee CH, Lui WY, Liu TJ, P'eng FK. Su CH, et al. Among authors: king kl. Ann Surg. 1996 Apr;223(4):384-94. doi: 10.1097/00000658-199604000-00007. Ann Surg. 1996. PMID: 8633917 Free PMC article.

2

Randomized trial of three types of gastrojejunostomy in unresectable periampullary cancer.

Shyr YM, Su CH, King KL, Wang HC, Lo SS, Wu CW, Lui WY. Shyr YM, et al. Among authors: king kl. Surgery. 1997 May;121(5):506-12. doi: 10.1016/s0039-6060(97)90104-5. Surgery. 1997. PMID: 9142148 Clinical Trial.

3

Prognostic significance of surgical margin in hepatocellular carcinoma resection: an analysis of 165 Childs' A patients.

Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Chiu JH, Wu CW, P'eng FK. Chau GY, et al. Among authors: king kl. J Surg Oncol. 1997 Oct;66(2):122-6. doi: 10.1002/(sici)1096-9098(199710)66:2<122::aid-jso9>3.0.co;2-f. J Surg Oncol. 1997. PMID: 9354168

4

Surgical treatment and outcome in patients with a hepatocellular carcinoma greater than 10 cm in diameter.

Lee NH, Chau GY, Lui WY, King KL, Tsay SH, Wu CW. Lee NH, et al. Among authors: king kl. Br J Surg. 1998 Dec;85(12):1654-7. doi: 10.1046/j.1365-2168.1998.00918.x. Br J Surg. 1998. PMID: 9876069

5

Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma.

Chau GY, Wu CW, Lui WY, Chang TJ, Kao HL, Wu LH, King KL, Loong CC, Hsia CY, Chi CW. Chau GY, et al. Among authors: king kl. Ann Surg. 2000 Apr;231(4):552-8. doi: 10.1097/00000658-200004000-00015. Ann Surg. 2000. PMID: 10749617 Free PMC article.

6

Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinoma.

Huang YH, Wu JC, Lui WY, Chau GY, Tsay SH, Chiang JH, King KL, Huo TI, Chang FY, Lee SD. Huang YH, et al. Among authors: king kl. World J Surg. 2000 May;24(5):551-5. doi: 10.1007/s002689910090. World J Surg. 2000. PMID: 10787075 Clinical Trial.

7

Better post-resectional survival in female cirrhotic patients with hepatocellular carcinoma.

Lee CC, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Hshia CY, Wu CW. Lee CC, et al. Among authors: king kl. Hepatogastroenterology. 2000 Mar-Apr;47(32):446-9. Hepatogastroenterology. 2000. PMID: 10791210

8

Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma.

Tsai TJ, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Hsia CY, Wu CW. Tsai TJ, et al. Among authors: king kl. Surgery. 2000 Jun;127(6):603-8. doi: 10.1067/msy.2000.105498. Surgery. 2000. PMID: 10840353

9

Hepatic segmentectomy for curative resection of primary hepatocellular carcinoma.

Lui WY, Chau GY, Loong CC, Tsay SH, Wu JC, King KL, Chiu JH, Lai CR, P'eng FK. Lui WY, et al. Among authors: king kl. Arch Surg. 1995 Oct;130(10):1090-7. doi: 10.1001/archsurg.1995.01430100068014. Arch Surg. 1995. PMID: 7575122

10

Retroperitoneal cystic lymphangioma in adults.

Chau GY, King KL, Su CH, Lui WY. Chau GY, et al. Among authors: king kl. Int Surg. 1993 Jul-Sep;78(3):243-6. Int Surg. 1993. PMID: 8161371

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters